Body Re-composition
Peptide research investigating pathways relevant to growth, body development, and lean tissue composition — including compounds studied in developmental research contexts such as paediatric growth deficiency and age-related decline in physiological growth signalling.
Growth hormone axis peptides have been extensively investigated for their role in somatic growth, lean mass accretion research, and cellular repair pathways across multiple preclinical and clinical research programmes (Walker, R.F., Clinical Interventions in Aging, 2006).

HCG
Strength
HCG — Human Chorionic Gonadotropin. LH analogue for testosterone support, fertility preservation, and HPTA recovery. Sub-Q administration in IU dosing.
For research purposes only

CJC/IPA
Strength
Pre-mixed lyophilised powder blend of CJC-1295 and Ipamorelin — not a liquid. Dual-pathway growth hormone research compound.
For research purposes only

KPV
Strength
A naturally occurring anti-inflammatory tripeptide derived from α-MSH, offering potent gut healing, skin repair, and systemic inflammation control via NF-κB pathway inhibition.
For research purposes only

IGF-1 LR3
Strength
A modified analogue of IGF-1 with extended half-life and IGFBP resistance, delivering potent anabolic and tissue-repair effects for muscle growth, body composition, and recovery research.
For research purposes only

Sermorelin
Strength
A synthetic GHRH analogue that stimulates the pituitary to release growth hormone in natural pulses — supporting body composition, sleep quality, fat loss, and longevity.
For research purposes only

HGH (Human Growth Hormone)
Strength
Recombinant HGH for growth, metabolism, and tissue repair research.
For research purposes only

Tesamorelin
Strength
GHRH analogue investigated for visceral fat reduction and GH axis research.
For research purposes only

CJC-1295 (with DAC)
Strength
Long-acting GHRH analogue with DAC for sustained GH release research.
For research purposes only

Retatrutide
Strength
Triple receptor agonist with the highest weight reduction reported in phase 2 trials.
For research purposes only

BPC-157
Strength
Pentadecapeptide studied for tissue repair and healing.
For research purposes only

CJC-1295 (no DAC)
Strength
Modified GRF peptide for growth hormone research.
For research purposes only

TB-500 (Thymosin Beta-4)
Strength
43-amino acid peptide for tissue regeneration research.
For research purposes only
